ARCHIVES

FDA Proposes New User Fees for Generics and Biosimilar Products

This article is from The Cancer Letter archive.

Vol. 38 No. 03 | January 20, 2012

Download PDF Visit The Full Archive

Related Articles

Bill Introduced To Ban Smoking From All Flights

March 24, 1989

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

October 28, 2011

Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases

August 26, 2011

MIT Researcher Ingested P-32; NRC Investigating

October 27, 1995

In Brief: Jack White Resigns As Director Of Howard Cancer Center; Roberson to Retire From Centers Program

June 1, 1984

DCE Concepts Approved

June 27, 1986